Company news
Firebrick Pharma Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Notification regarding unquoted securities - FRE
November 16, 2026
Change of Director's Interest Notice - Stephen Goodall
November 16, 2026
Change of Director's Interest Notice - Rick Legleiter
November 16, 2026
Change of Director's Interest Notice - Peter Molloy
November 16, 2026
Change of Director's Interest Notice - Al Moghaddam
November 16, 2026
Proposed issue of securities - FRE
November 11, 2026
Results of Annual General Meeting
November 10, 2026
September 2026 Quarterly Activity Report & Appendix 4C
October 22, 2026
New Product - Nasodine Sinus Rinse
October 20, 2026
New Product - Nasodine Sinus Rinse
October 20, 2026
Change in substantial holding - Pharma Nutria
October 19, 2026
Cleansing Notice
October 18, 2026
Application for quotation of securities - FRE
October 18, 2026
Nasodine Nasal Spray Approved in the Philippines
October 15, 2026
Notice of AGM & Proxy Form & Letter to Shareholders
October 11, 2026
Proposed issue of securities - FRE
October 11, 2026
Firebrick Secures $732k in Strategic Investments
October 11, 2026
Firebrick Investor Update Presentation
October 6, 2026
Firebrick announces USA Retail Launch Plan
September 28, 2026
Firebrick receives $293,000 R&D Tax Incentive
September 22, 2026
Notice of AGM and Closing Date for Director Nominations
September 14, 2026
Appendix 4E and Annual Report 30 June 2026
August 31, 2026
Appendix 4G
August 31, 2026
Corporate Governance Statement
August 31, 2026
Cleansing Notice
August 10, 2026
Application for quotation of securities - FRE
August 10, 2026
Proposed issue of securities - FRE
August 9, 2026
Investor Update
July 26, 2026
March 2026 Quarterly Activity Report & Appendix 4C
April 21, 2026
Firebrick Secures $1.5 million via Placement
March 30, 2026
Trading Halt
March 26, 2026
Registration Agreement and Approval of Nasodine in Indonesia
March 26, 2026
Appendix 4D & Half-Year Financial Report to 31 December 2025
February 24, 2026
December 2025 Quarterly Activity Report & Appendix 4C
January 27, 2026
Nasodine Throat Spray Product Launch in Singapore
January 20, 2026
Firebrick announces new product Nasodine Throat Spray
October 29, 2025
September 2025 Quarterly Activity Report & Appendix 4C
October 22, 2025
Firebrick Secures Investment from Philippines Partner
October 15, 2025
Firebrick receives $250,000 R&D Tax Incentive
September 9, 2025
Appendix 4E and Annual Report 30 June 2025
August 29, 2025
Firebrick Secures $1.4 million via Placement
August 25, 2025
License Agreement for Singapore, Malaysia, Brunei, Mauritius
August 25, 2025
June 2025 Quarterly Activity Report & Appendix 4C
July 22, 2025
Firebrick Closes Placement at $0.2 milliion
June 25, 2025
Withdrawal of Share Placement
June 6, 2025
March 2025 Quarterly Activity Report & Appendix 4C
April 16, 2025
FRE secures Strategic Investment from Philippines Partner
March 3, 2025
Appendix 4D & Half-Year Financial Report to 31 December 2024
February 20, 2025
December 2024 Quarterly Activity Report & Appendix 4C
January 22, 2025
Nasodine Retail Pharmacy Launch in Singapore
November 24, 2024
Decks
The 5 newest of 9 decks. Every deck is listed under its year.
- Aussie Equities Day, Singapore 2026
Conference · 15 slides · Oct 7, 2026
- Investor Presentation (March 2026)
Investor deck · 18 slides · Mar 4, 2026
- Shareholder Meeting (November 2025)
Shareholder meeting · 24 slides · Nov 26, 2025
- Investor Presentation (June 2025)
Investor deck · 20 slides · Jun 23, 2025
- Shareholder Meeting (November 2024)
Shareholder meeting · 18 slides · Nov 27, 2024